If you need more lookups,
subscriptions start at $34 USD/month.
Luke Lee Location
Seoul, South Korea
Luke Lee Work
2023 -now Chief Executive Officer @
2023 -now Member Board of Directors @
2023 -2025 Member Board of Directors @
2023 -2023 Sr Strategy Advisor @ Bertis Bioscience
2020 -2023 Chief Executive Officer @
2016 -2020 President and General Manager @
2012 -2017 General Manager @
2010 -2012 President and General Manager @ Eli Lilly and Company
2007 -2009 District Sales Manager @ Eli Lilly and Company
2005 -2007 Clinical Development, Medical and Regulatory Affairs Director @ Eli Lilly and Company
2003 -2005 Medical Liaison Team Leader @ Eli Lilly and Company
2001 -2003 Senior Associate @ Eli Lilly and Company
1999 -2001 Founder, VP of Business Development in Asia @ eTechtransfer.com
2000 -2000 Research Analyst in Biotechnology EU market @ Lehman Brothers
1999 -1999 Summer intern @
Luke Lee Education
University of Pennsylvania - The Wharton School 1999-2001
Seoul National University 1997-1999
한림대학교(Hallym University) 1988-1996
Luke Lee Skills
Restructuring
CRO
Medical Devices
Clinical Development
Biotechnology
Pharmaceutical Industry
Diabetes
Regulatory Affairs
Oncology
Mergers & Acquisitions
CTMS
Medicine
Clinical Research
Market Access
Pharmaceutics
Strategic Planning
Strategy
Mergers and Acquisitions
Customer Service
Management
Microsoft Word
Great
Research
Project Management
Has Errors
Sales Management
Luke Lee Summary
Luke Lee, based in Seoul, South Korea, is currently a Chief Executive Officer at NOBO Medicine. Luke Lee brings experience from previous roles at Pharmascience, innocure therapeutics, Bertis Bioscience and shaperon. Luke Lee holds a 1999 - 2001 University of Pennsylvania - The Wharton School. With a robust skill set that includes Restructuring, CRO, Medical Devices, Clinical Development, Biotechnology and more. Luke Lee has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Luke Lee?
Find contact details for 700 million professionals.